Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 10th June 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

European Commission approves Elanco's acquisition of Bayer Animal Health
"We look forward to turning our full attention to delivering innovation"  - Jeff Simmons, Elanco.

Approval "an important milestone" toward completion.

The proposed acquisition of Bayer's animal health division by Elanco has been approved by the European Commission (EC).

In a press release, Elanco said that it continues to progress toward a mid-year closing, anticipated August 3, 2020. The deal, valued at $7.6 billion, would see Elanco become the second largest company in the animal health sector.

“Approval from the European Commission is an important milestone toward the completion of our acquisition of Bayer Animal Health," commented Jeff Simmons, president and CEO of Elanco.

“As the transaction edges closer to fruition, we look forward to turning our full attention to delivering innovation and an expanded portfolio of solutions for farmers, veterinarians and pet owners across the globe."

Elanco previously announced divestiture agreements, in the range of $120 million to $140 million, to help advance the needed regulatory reviews. The EC’s approval is conditional on several of these proposed divestitures, including:

  • divestiture of the worldwide rights for Osurnia® to Dechra Pharmaceuticals
  • divestiture of the worldwide rights for Vecoxan® to Merck Animal Health
  • divestiture of European Economic Area and UK rights to the Drontal® and Profender® product families, and related pipeline assets, from Bayer Animal Health to Vetoquinol.
     
Mr Simmons continued: “The recent months have only underscored the critical work our farmers do in delivering meat, milk, fish and eggs, and the importance of providing pet owners and veterinarians with a variety of solutions in multiple channels from telemedicine and e-commerce to direct home delivery. Combining Bayer Animal Health’s leadership in these areas better positions Elanco to deliver on these needs.”

 

Become a member or log in to add this story to your CPD history

Free CPD announced for BVNA members

News Story 1
 Zoetis is to present a CPD event for free to members of the British Veterinary Nursing Association (BVNA).

Led by veterinary consultant Ruth Moxon, the one-hour online session is designed to help veterinary nurses discuss parasiticide options with clients. It will advise on structuring recommendations, factors for product choice and moving away from 'selling'.

'How do you recommend parasite treatments to your clients?' will be presented on Tuesday, 20 May at 7.30pm. It is free for BVNA members, with 15.00 tickets for non-members.

Veterinary nurses can email cpd@bvna.co.uk to book their place. 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.